Medtronic supply woes buoy insulin device makers

Share prices for makers of insulin management devices got a bump today after Medtronic (NYSE:MDT) reported today that supply problems pushed sales down -1% for its diabetes division. The Fridley, Minn.-based company, which released its fiscal 2018 first-quarter results this morning, posted diabetes revenues of $449 million for the three months ended July 28. The decline was driven by strong demand for Medtronic’s CGM-enabled insulin pumps, especially the MiniMed 670G hybrid closed-loop device. Get the full story at our sister site, Drug Delivery Business News. The post Medtronic supply woes buoy insulin device makers appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Diabetes MassDevice Earnings Roundup Wall Street Beat Dexcom Insulet Medtronic Tandem Diabetes Care Source Type: news